Pliant Therapeutics announced that the latest data from the Phase 1 clinical trial of its investigational drug Pln-101095 for patients with immune checkpoint inhibitor (ICI)-refractory solid tumors will be presented in a special report at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Pliant Therapeutics announced that the latest data from the Phase 1 clinical trial of its investigational drug Pln-101095 for patients with immune checkpoint inhibitor (ICI)-refractory solid tumors will be presented in a special report at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This groundbreaking study aims to evaluate the safety and preliminary efficacy of Pln-101095 in patients with advanced solid tumors, providing new potential directions for tumor immunotherapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Investors Want Anthropic's IPO Price First: Is That Why OpenAI Cut $10 Billion?
BeInCrypto•2026/11/02 05:09
Rebound short target 76,300, the short-term goal has already been achieved!
AiCoin•2026/11/02 04:33
Crypto prices
More
Bitcoin
BTC
$78,306.81
+0.79%
Ethereum
ETH
$2,291.92
+1.27%
Tether USDt
USDT
$0.9986
-0.01%
BNB
BNB
$710.07
+0.80%
XRP
XRP
$1.25
+0.15%
USDC
USDC
$0.9996
-0.01%
Solana
SOL
$94.96
-0.49%
TRON
TRX
$0.3141
+1.20%
Hyperliquid
HYPE
$87.72
-0.09%
Zcash
ZEC
$1,275.72
+2.61%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now